4//SEC Filing
INVIVO THERAPEUTICS HOLDINGS CORP. 4
Accession 0001179110-17-001102
CIK 0001292519operating
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 2:03 PM ET
Size
5.5 KB
Accession
0001179110-17-001102
Insider Transaction Report
Form 4
Ulich Thomas R
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-01-18+150,000→ 150,000 totalExercise: $4.35Exp: 2027-01-18→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the shares on the first anniversary of the date of grant, and the remaining shares vest thereafter on a monthly basis in 36 equal monthly installments.
Documents
Issuer
INVIVO THERAPEUTICS HOLDINGS CORP.
CIK 0001292519
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001292519
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 2:03 PM ET
- Size
- 5.5 KB